Physician profile
Robert Jarvis
NPI 1629163274
$943.16
in general payments reported to CMS, 2019-2025
8 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $14.22 · 2021: $112 · 2022: $180 · 2023: $219 · 2024: $124 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $717.44 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $115.46 | 2019 | |
| Brainsway USA INC | $26.75 | 2024 | Brainsway Deep Tms System |
| Corium, LLC | $25.68 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.61 | 2022 | |
| Eisai INC. | $14.22 | 2020 | |
| Axsome Therapeutics, INC. | $14.00 | 2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $14.00 | 2025 | Fanapt, Hetlioz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jarvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.